Literature DB >> 33692650

Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers.

Chendi Niu1, Yi Du1, Igor A Kaltashov1.   

Abstract

Neutrophil elastase is a serine protease released by neutrophils, and its dysregulation has been associated with a variety of debilitating pathologies, most notably cystic fibrosis. This protein is also a prominent component of the so-called neutrophil extracellular traps (NETs), whose formation is a part of the innate immunity response to invading pathogens, but also contributes to a variety of pathologies ranging from autoimmune disorders and inflammation to cancer to thrombotic complications in COVID-19. Retention of neutrophil elastase within NETs is provided by ejected DNA chains, although this protein is also capable of interacting with a range of other endogenous polyanions, such as heparin and heparan sulfate. In this work, we evaluate the feasibility of using native mass spectrometry (MS) as a means of studying interactions of neutrophil elastase with heparin oligomers ranging from structurally homogeneous synthetic pentasaccharide fondaparinux to relatively long (up to twenty saccharide units) and structurally heterogeneous chains produced by partial depolymerization of heparin. The presence of heterogeneous glycan chains on neutrophil elastase and the structural heterogeneity of heparin oligomers render the use of standard MS to study their complexes impractical. However, supplementing MS with limited charge reduction in the gas phase allows meaningful data to be extracted from MS measurements. In contrast to earlier molecular modeling studies where a single heparin-binding site was identified, our work reveals the existence of multiple binding sites, with a single protein molecule being able to accommodate up to three decasaccharides. The measurements also reveal the ability of even relatively short heparin oligomers to bridge two protein molecules, suggesting that characterization of these complexes using native MS can shed light on the structural properties of NETs. Lastly, the use of MS allows the binding preferences of heparin oligomers to neutrophil elastase to be studied with respect to specific structural properties of heparin, such as the level of sulfation (i.e., charge density). All experimental measurements are carried out in parallel with molecular dynamics simulations of the protein/heparin oligomer systems, which are in remarkable agreement with the experimental data and highlight the role of electrostatic interactions as dominant forces governing the formation of these complexes.

Entities:  

Year:  2021        PMID: 33692650      PMCID: PMC7939139          DOI: 10.1016/j.ijms.2021.116550

Source DB:  PubMed          Journal:  Int J Mass Spectrom        ISSN: 1387-3806            Impact factor:   1.986


  47 in total

1.  Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin.

Authors:  Nicholas J Harmer; Christopher J Robinson; Lucy E Adam; Leopold L Ilag; Carol V Robinson; John T Gallagher; Tom L Blundell
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

2.  Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.

Authors:  Valerie Vivat Hannah; C Atmanene; D Zeyer; A Van Dorsselaer; Sarah Sanglier-Cianférani
Journal:  Future Med Chem       Date:  2010-01       Impact factor: 3.808

3.  Platelet Factor 4 Interactions with Short Heparin Oligomers: Implications for Folding and Assembly.

Authors:  Chendi Niu; Yang Yang; Angela Huynh; Ishac Nazy; Igor A Kaltashov
Journal:  Biophys J       Date:  2020-04-21       Impact factor: 4.033

4.  On-line size-exclusion chromatography/mass spectrometry of low molecular mass heparin.

Authors:  Jens Henriksen; Lene Hoffmeyer Ringborg; Peter Roepstorrf
Journal:  J Mass Spectrom       Date:  2004-11       Impact factor: 1.982

5.  COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.

Authors:  Alexander Makatsariya; Ekaterina Slukhanchuk; Viktoriya Bitsadze; Jamilya Khizroeva; Maria Tretyakova; Valentina Tsibizova; Andrey Dobryakov; Ismail Elalamy; Jean C Gris
Journal:  J Perinat Med       Date:  2020-11-26       Impact factor: 1.901

6.  Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.

Authors:  Rinat R Abzalimov; Paul L Dubin; Igor A Kaltashov
Journal:  Anal Chem       Date:  2007-07-21       Impact factor: 6.986

7.  Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.

Authors:  Burcu B Minsky; Rinat R Abzalimov; Chendi Niu; Yunlong Zhao; Zachary Kirsch; Paul L Dubin; Sergey N Savinov; Igor A Kaltashov
Journal:  Biochemistry       Date:  2018-07-25       Impact factor: 3.162

8.  Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19.

Authors:  Alain R Thierry
Journal:  Physiol Rev       Date:  2020-10-01       Impact factor: 37.312

9.  The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19).

Authors:  Angélica Arcanjo; Jorgete Logullo; Camilla Cristie Barreto Menezes; Thais Chrispim de Souza Carvalho Giangiarulo; Mirella Carneiro Dos Reis; Gabriellen Menezes Migliani de Castro; Yasmin da Silva Fontes; Adriane Regina Todeschini; Leonardo Freire-de-Lima; Debora Decoté-Ricardo; Antônio Ferreira-Pereira; Celio Geraldo Freire-de-Lima; Shana Priscila Coutinho Barroso; Christina Takiya; Fátima Conceição-Silva; Wilson Savino; Alexandre Morrot
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

10.  Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.

Authors:  Coraline Radermecker; Nancy Detrembleur; Julien Guiot; Etienne Cavalier; Monique Henket; Céline d'Emal; Céline Vanwinge; Didier Cataldo; Cécile Oury; Philippe Delvenne; Thomas Marichal
Journal:  J Exp Med       Date:  2020-12-07       Impact factor: 14.307

View more
  1 in total

Review 1.  Patients with COVID-19: in the dark-NETs of neutrophils.

Authors:  Maximilian Ackermann; Hans-Joachim Anders; Rostyslav Bilyy; Gary L Bowlin; Christoph Daniel; Rebecca De Lorenzo; Mikala Egeblad; Timo Henneck; Andrés Hidalgo; Markus Hoffmann; Bettina Hohberger; Yogendra Kanthi; Mariana J Kaplan; Jason S Knight; Jasmin Knopf; Elzbieta Kolaczkowska; Paul Kubes; Moritz Leppkes; Aparna Mahajan; Angelo A Manfredi; Christian Maueröder; Norma Maugeri; Ioannis Mitroulis; Luis E Muñoz; Teluguakula Narasaraju; Elisabeth Naschberger; Indira Neeli; Lai Guan Ng; Marko Z Radic; Konstantinos Ritis; Patrizia Rovere-Querini; Mirco Schapher; Christine Schauer; Hans-Uwe Simon; Jeeshan Singh; Panagiotis Skendros; Konstantin Stark; Michael Stürzl; Johan van der Vlag; Peter Vandenabeele; Ljubomir Vitkov; Maren von Köckritz-Blickwede; Cansu Yanginlar; Shida Yousefi; Alexander Zarbock; Georg Schett; Martin Herrmann
Journal:  Cell Death Differ       Date:  2021-05-24       Impact factor: 15.828

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.